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ABSTRACT 
NSAIDs (nonsteroidal anti-inflammatory drugs) are a class of drugs with analgesic, anti-
inflammatory, and antipyretic effects. Diclofenac sodium is one of the world's most widely-
prescribed NSAIDs. Meloxicam is another NSAID that was approved in the last several years. 
Treatment with NSAIDs may result in renal damage. Relatively, little is known about com-
parative nephrotoxicity of NSAIDs. Therefore, the present study was designed to compare the 
adverse effects of diclofenac sodium and meloxicam on renal tissue in rats. 
 
Forty eight Wistar male rats were randomly assigned into 3 groups of 16 animals each. Group 
C served as normal control and received normal saline. Group D and M received diclofenac 
sodium (2.3 mg/kg/day) and meloxicam (2.3 mg/kg/day), respectively. After 17 days, all rats 
were scarified. Their kidneys were then harvested and processed for histological examination. 
In addition to cellular details, renal tubular count and diameter were assessed with the light 
microscope. The data were analyzed using SPSS software. 
 
We found that the mean number of renal tubules was significantly lower in group D, than in 
group C. Moreover, the mean renal tubular diameter was significantly higher in group D than 
in group C.  
 
The present study showed that a considerable degree of nephrotoxicity resulted from di-
clofenac sodium, compared to meloxicam. We suggest that diclofenac sodium can be replaced 
with meloxicam.  
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tory drugs) are a class of drugs with analge-
sic, anti-inflammatory, and antipyretic ef-
fects (Litalien and Jacqz-Aigrain, 2001). 
The majority of NSAIDs inhibit the COX 
(cyclooxygenase) enzymes (Raz, 2002) and 
therefore influence the production of pros-
taglandins (Chandrasekharan et al., 2002), 
and in doing so, treatment with NSAIDs 
results in hepatic, gastrointestinal, and renal 
damage (McCarthy, 1998; Wolfe, 1998; 
Bjorkman, 1998; Fruchter et al., 2011). 
There are two isoforms of COX (Xie et al., 
1991). COX1 is expressed in gastrointesti-
nal tissue, in kidney and in platelets, and 
serves a protective and regulatory function 
(Smith and Dewitt, 1996). COX2 is present 
in low concentrations in most normal tis-
sues such as kidney, liver, and lung (Seibert 
et al., 1994). The inflammatory process is 
also influenced by COX enzymes (Sano et 
al., 1992), especially COX2 (Crofford et al., 
1994). 
Diclofenac sodium (marketed under the 
trade names Cataflam and Voltaren) is one 
of the world's most widely-prescribed 
NSAIDs. Meloxicam (marketed under the 
brand name Mobic, among other names) is 
another NSAID that was approved in the 
last several years. Diclofenac sodium inhib-
its both COX1 and COX2 (Quiralte et al., 
2007), however, meloxicam is a selective 
COX2 inhibitor (Furst, 1997; Gurocak et 
al., 2010). Compared to meloxicam, di-
clofenac sodium resulted in a high degree 
of nephrotoxicity (Swan et al., 2006). The 
damaging effects of diclofenac sodium and 
meloxicam on kidney tissue in human and 
animals is well-documented in the litera-
ture. Nevertheless, no single study exists 
that adequately compares the histopa-
thological effects of these two NSAIDs on 
renal tissue. The present study compares the 
adverse effects of diclofenac sodium and 
meloxicam on kidney tissue in rats. 
 
MATERIALS AND METHODS 
 
Forty eight male 8-week-old Wistar rats 
(190 to 220 grams) were randomly assigned 
into 3 groups of 16 animals each. Group C 
served as normal control and received nor-
mal saline. Group D and M received di-
clofenac sodium (2.3 mg/kg/day) and 
meloxicam (2.3 mg/kg/day), respectively. 
Rats were housed under controlled envi-
ronmental conditions with ambient tem-
perature of 19 °C, relative humidity of 
55±10 % and 12-h light/dark cycle. Stan-
dard pelleted  chow and water were pro-
vided ad libitum. All the experimental pro-
cedures were conducted according to proto-
cols approved by the Animal Care Commit-
tee of the Tabriz University of Medical Sci-
ences. After a period of 17 days, rats were 
scarified. Their kidneys were then har-
vested and processed for histological ex-
amination. A full cross-sectional face of 
each kidney was processed and stained with 
PAS (Periodic Acid Schiff) and H&E (He-
matoxylin & Eosin) and analyzed under 
Olympus light microscope. Using counting 
reticule, tubular count was made in five se-
lected fields in the cortex of kidney. Tubu-
lar diameter was also measured by means of 
ocular micrometer. Finally, statistical 
analyses were performed using the SPSS 
statistical software package (Version 17.0). 
More precisely, data were analyzed by one-
way ANOVA and Tukey post hoc tests, and 




H&E staining showed that glomeruli 
and renal tubules were normal in group C. 
There was no sign of degeneration in the 
cortex and medulla of the kidneys. The 
mean number of convoluted tubules was 
23.56. The mean tubular diameter was 
51.1 µm. The basement membrane of tu-
bules was quite normal. Moreover, PAS 
staining did not reveal any damage in brush 
border. The content of glycogen in proxi-
mal and distal tubules was fairly normal. 
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H&E staining revealed that nuclei were 
condensed in group D. Proximal and distal 
convoluted tubules were dilated. The mean 
tubular diameter was 53.1 µm. Degenera-
tive changes were found in the proximal 
and distal convoluted tubules. The mean 
number of tubules was 21.31. PAS staining 
showed that the brush border was severely 
damaged at some places. The glycogen con-
tent was decreased in both proximal and 
distal tubules. 
H&E staining showed that glomeruli 
and renal tubules were quite normal in 
group M. The mean number of renal convo-
luted tubules was 23.06. The mean renal 
tubular diameter was 51.9 µm. Any abnor-
mality was not found in the basement 
membrane of renal cells. PAS staining re-
vealed that the brush border was normal. 
There was a negligible decrease in the con-
tent of glycogen in the proximal and distal 
tubules. 
Data analysis showed that the mean 
number of renal tubules was significantly 
lower in group D, than group C (P=0.021). 
In addition, the mean renal tubular diameter 
was significantly higher in group D than in 
group C (P=0.003). 
 
 
Figure 1: Comparison of tubular count (TC) 
between control (C), diclofenac sodium (D), and 
meloxicam (M) groups (mean±standard devia-
tion) 
* P-value<0.05 compared to control group 
(based on Tuckey post hoc test) 
 
 
Figure 2: Comparison of tubular diameter (TD) 
between control (C), diclofenac sodium (D), and 
meloxicam (M) groups, (mean±standard devia-
tion) 
* P-value<0.05 compared to control group 




Renal prostaglandins have crucial local 
functions. Prostaglandins are present in dif-
ferent parts of kidney such as glomeruli and 
convoluted tubules (Bonvalet et al., 1987; 
Farman et al., 1987; Stahl et al., 1984). 
Prostaglandin inhibitors have various 
physiologic effects (Flower, 1974). It is 
generally thought that NSAIDs have 
nephrotoxic impacts. Some studies were 
conducted on the adverse effects of 
NSAIDs on kidney (Hickey et al., 2001; 
Swan et al., 2006), Nonetheless, little is 
known about comparative deleterious ef-
fects of NSAIDs on renal tissue. Hence, 
present study was undertaken to investigate 
the nephrotoxic potential of diclofenac so-
dium and meloxicam. 
We observed that the number of distal 
and proximal convoluted tubules was sig-
nificantly less in group D as compared to 
group C. Our results seem to be consistent 
with other research which found that renal 
tissue was damaged by  treatment with di-
clofenac sodium (Aydin et al., 2003). It was 
suggested that the diclofenac-induced renal 
damage may be associated with ischemia 
caused by inhibition of prostaglandins syn-
thesis in renal arterioles (Yasmeen et al., 
2007). It was shown that Indomethacim, 
which is an NSAID, resulted in vacuolar 
degeneration of proximal tubules and focal 
tubular atrophy (Gary et al., 1980; Clive 
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and Stoff, 1984). We observed that proxi-
mal and distal convoluted tubules were sig-
nificantly dilated in Group D, in compari-
son with group C. Our results corroborated 
the findings of Scott (1966), who reported 
that diclofenac sodium resulted in transient 
shedding in renal cells. Another study indi-
cated that treatment with diclofenac sodium 
gave rise to necrosis of endothelial cells in 
the renal corpuscles (Triebskorn et al., 
2004). Furthermore, we did not find any 
significant renal tissue damage in group M. 
However, Rauser et al. (2010) reported that 
there was mild renal tubular damage in 
meloxicam-treated pigs. Ng et al. (2008) 
reported that diclofenac sodium resulted in 
severe renal damage. They also suggested 
that diclofenac sodium can be replaced with 
meloxicam. 
In conclusion, the results of the present 
study showed that a considerable degree of 
nephrotoxicity resulted from diclofenac so-
dium, compared to meloxicam. Therefore, 
we suggest that diclofenac sodium can be 
replaced with meloxicam. Finally, further 
research is needed on comparative adverse 
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